The emerging role of olanzapine in paediatric CINV control: A review.

Medicine (Baltimore) · 2022 · PMC9771166 · PMID 36550859

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

The trial findings on superiority of olanzapine, compared to metoclopramide in treating pediatric breakthrough CINV failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.